BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhong X, Zhu Y, Lu Q, Zhang J, Ge Z, Zheng S. Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway. Toxicology 2006;227:211-6. [PMID: 16949716 DOI: 10.1016/j.tox.2006.07.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Anjum J, Mitra S, Das R, Alam R, Mojumder A, Bin Emran T, Islam F, Rauf A, Hossain MJ, Aljohani ASM, Abdulmonem WA, Alsharif KF, Alzahrani KJ, Khan H. A Renewed Concept on the MAPK Signaling Pathway in Cancers: Polyphenols as a Choice of Therapeutics. Pharmacol Res 2022;:106398. [PMID: 35988867 DOI: 10.1016/j.phrs.2022.106398] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Koltai T, Fliegel L. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. J Evid Based Integr Med 2022;27:2515690X211068826. [PMID: 35018864 DOI: 10.1177/2515690X211068826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sekar P, Ravitchandirane R, Khanam S, Muniraj N, Cassinadane AV. Novel molecules as the emerging trends in cancer treatment: an update. Med Oncol 2022;39:20. [PMID: 34982273 DOI: 10.1007/s12032-021-01615-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Egbuna C, Patrick-Iwuanyanwu KC, Onyeike EN, Khan J, Alshehri B. FMS-like tyrosine kinase-3 (FLT3) inhibitors with better binding affinity and ADMET properties than sorafenib and gilteritinib against acute myeloid leukemia: in silico studies. J Biomol Struct Dyn 2021;:1-12. [PMID: 34486940 DOI: 10.1080/07391102.2021.1969286] [Reference Citation Analysis]
5 Mashhadi Akbar Boojar M, Mashhadi Akbar Boojar M, Golmohammad S. Overview of Silibinin anti-tumor effects. Journal of Herbal Medicine 2020;23:100375. [DOI: 10.1016/j.hermed.2020.100375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Kim SH, Choo GS, Yoo ES, Woo JS, Han SH, Lee JH, Jung JY. Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells. Oncol Rep 2019;42:1904-14. [PMID: 31485597 DOI: 10.3892/or.2019.7295] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
7 Won D, Kim L, Jang B, Yang I, Kwon H, Jin B, Oh SH, Kang J, Hong S, Shin J, Cho S. In vitro and in vivo anti-cancer activity of silymarin on oral cancer. Tumour Biol 2018;40:101042831877617. [DOI: 10.1177/1010428318776170] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
8 Comelli MC, Mengs U, Schneider C, Prosdocimi M. Toward the Definition of the Mechanism of Action of Silymarin: Activities Related to Cellular Protection From Toxic Damage Induced by Chemotherapy. Integr Cancer Ther 2007;6:120-9. [DOI: 10.1177/1534735407302349] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 12.0] [Reference Citation Analysis]
9 Noori-daloii MR, Saffari M, Raoofian R, Yekaninejad M, Dinehkabodi OS, Noori-daloii AR. The multidrug resistance pumps are inhibited by silibinin and apoptosis induced in K562 and KCL22 leukemia cell lines. Leukemia Research 2014;38:575-80. [DOI: 10.1016/j.leukres.2013.10.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
10 Cho SI, Lee J, Do NY. Protective effect of silymarin against cisplatin-induced ototoxicity. International Journal of Pediatric Otorhinolaryngology 2014;78:474-8. [DOI: 10.1016/j.ijporl.2013.12.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
11 Milić N, Milošević N, Suvajdžić L, Žarkov M, Abenavoli L. New Therapeutic Potentials of Milk Thistle ( Silybum marianum ). Natural Product Communications 2013;8:1934578X1300801. [DOI: 10.1177/1934578x1300801236] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Su CH, Chen LJ, Liao JF, Cheng JT. Increase of phosphatase and tensin homolog by silymarin to inhibit human pharynx squamous cancer. J Med Food. 2013;16:778-784. [PMID: 23909904 DOI: 10.1089/jmf.2012.2534] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
13 Yu HC, Chen LJ, Cheng KC, Li YX, Yeh CH, Cheng JT. Silymarin inhibits cervical cancer cell through an increase of phosphatase and tensin homolog. Phytother Res. 2012;26:709-715. [PMID: 22016029 DOI: 10.1002/ptr.3618] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
14 Theodosiou E, Loutrari H, Stamatis H, Roussos C, Kolisis FN. Biocatalytic synthesis and antitumor activities of novel silybin acylated derivatives with dicarboxylic acids. New Biotechnology 2011;28:342-8. [DOI: 10.1016/j.nbt.2011.01.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
15 Ninsontia C, Pongjit K, Chaotham C, Chanvorachote P. Silymarin selectively protects human renal cells from cisplatin-induced cell death. Pharm Biol 2011;49:1082-90. [PMID: 21591838 DOI: 10.3109/13880209.2011.568506] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
16 Cheah YH, Nordin FJ, Sarip R, Tee TT, Azimahtol HLP, Sirat HM, Rashid BAA, Abdullah NR, Ismail Z. Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cancer Cell Int 2009;9:1. [PMID: 19118501 DOI: 10.1186/1475-2867-9-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
17 Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008;269:352-362. [PMID: 18472213 DOI: 10.1016/j.canlet.2008.03.053] [Cited by in Crossref: 229] [Cited by in F6Publishing: 210] [Article Influence: 16.4] [Reference Citation Analysis]
18 Deorukhkar A, Krishnan S, Sethi G, Aggarwal BB. Back to basics: how natural products can provide the basis for new therapeutics. Expert Opin Investig Drugs 2007;16:1753-73. [PMID: 17970636 DOI: 10.1517/13543784.16.11.1753] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 6.2] [Reference Citation Analysis]
19 Gharagozloo M, Amirghofran Z. Effects of silymarin on the spontaneous proliferation and cell cycle of human peripheral blood leukemia T cells. J Cancer Res Clin Oncol 2007;133:525-32. [PMID: 17436018 DOI: 10.1007/s00432-007-0197-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]